RPL13AP20 and neoplasm: Heatmap indicated that NCF1C, HLA-DRB6, HLA-DPB2, HLA-J, HLA-H, HLA-L and RPL13AP20 displayed high expressions in the low-risk group, and thus were categorized as tumor-suppressor pseudogenes in the current study.